1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cobalt Chromium Stents (CCS) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cobalt Chromium Stents (CCS) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cobalt Chromium Stents (CCS) by Country/Region, 2018, 2022 & 2029
2.2 Cobalt Chromium Stents (CCS) Segment by Type
2.2.1 Uncoated Cobalt Chromium Stents
2.2.2 Coated Cobalt Chromium Stents
2.3 Cobalt Chromium Stents (CCS) Sales by Type
2.3.1 Global Cobalt Chromium Stents (CCS) Sales Market Share by Type (2018-2023)
2.3.2 Global Cobalt Chromium Stents (CCS) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cobalt Chromium Stents (CCS) Sale Price by Type (2018-2023)
2.4 Cobalt Chromium Stents (CCS) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Cobalt Chromium Stents (CCS) Sales by Application
2.5.1 Global Cobalt Chromium Stents (CCS) Sale Market Share by Application (2018-2023)
2.5.2 Global Cobalt Chromium Stents (CCS) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cobalt Chromium Stents (CCS) Sale Price by Application (2018-2023)
3 Global Cobalt Chromium Stents (CCS) by Company
3.1 Global Cobalt Chromium Stents (CCS) Breakdown Data by Company
3.1.1 Global Cobalt Chromium Stents (CCS) Annual Sales by Company (2018-2023)
3.1.2 Global Cobalt Chromium Stents (CCS) Sales Market Share by Company (2018-2023)
3.2 Global Cobalt Chromium Stents (CCS) Annual Revenue by Company (2018-2023)
3.2.1 Global Cobalt Chromium Stents (CCS) Revenue by Company (2018-2023)
3.2.2 Global Cobalt Chromium Stents (CCS) Revenue Market Share by Company (2018-2023)
3.3 Global Cobalt Chromium Stents (CCS) Sale Price by Company
3.4 Key Manufacturers Cobalt Chromium Stents (CCS) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cobalt Chromium Stents (CCS) Product Location Distribution
3.4.2 Players Cobalt Chromium Stents (CCS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cobalt Chromium Stents (CCS) by Geographic Region
4.1 World Historic Cobalt Chromium Stents (CCS) Market Size by Geographic Region (2018-2023)
4.1.1 Global Cobalt Chromium Stents (CCS) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cobalt Chromium Stents (CCS) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cobalt Chromium Stents (CCS) Market Size by Country/Region (2018-2023)
4.2.1 Global Cobalt Chromium Stents (CCS) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cobalt Chromium Stents (CCS) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cobalt Chromium Stents (CCS) Sales Growth
4.4 APAC Cobalt Chromium Stents (CCS) Sales Growth
4.5 Europe Cobalt Chromium Stents (CCS) Sales Growth
4.6 Middle East & Africa Cobalt Chromium Stents (CCS) Sales Growth
5 Americas
5.1 Americas Cobalt Chromium Stents (CCS) Sales by Country
5.1.1 Americas Cobalt Chromium Stents (CCS) Sales by Country (2018-2023)
5.1.2 Americas Cobalt Chromium Stents (CCS) Revenue by Country (2018-2023)
5.2 Americas Cobalt Chromium Stents (CCS) Sales by Type
5.3 Americas Cobalt Chromium Stents (CCS) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cobalt Chromium Stents (CCS) Sales by Region
6.1.1 APAC Cobalt Chromium Stents (CCS) Sales by Region (2018-2023)
6.1.2 APAC Cobalt Chromium Stents (CCS) Revenue by Region (2018-2023)
6.2 APAC Cobalt Chromium Stents (CCS) Sales by Type
6.3 APAC Cobalt Chromium Stents (CCS) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cobalt Chromium Stents (CCS) by Country
7.1.1 Europe Cobalt Chromium Stents (CCS) Sales by Country (2018-2023)
7.1.2 Europe Cobalt Chromium Stents (CCS) Revenue by Country (2018-2023)
7.2 Europe Cobalt Chromium Stents (CCS) Sales by Type
7.3 Europe Cobalt Chromium Stents (CCS) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cobalt Chromium Stents (CCS) by Country
8.1.1 Middle East & Africa Cobalt Chromium Stents (CCS) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cobalt Chromium Stents (CCS) Revenue by Country (2018-2023)
8.2 Middle East & Africa Cobalt Chromium Stents (CCS) Sales by Type
8.3 Middle East & Africa Cobalt Chromium Stents (CCS) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cobalt Chromium Stents (CCS)
10.3 Manufacturing Process Analysis of Cobalt Chromium Stents (CCS)
10.4 Industry Chain Structure of Cobalt Chromium Stents (CCS)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cobalt Chromium Stents (CCS) Distributors
11.3 Cobalt Chromium Stents (CCS) Customer
12 World Forecast Review for Cobalt Chromium Stents (CCS) by Geographic Region
12.1 Global Cobalt Chromium Stents (CCS) Market Size Forecast by Region
12.1.1 Global Cobalt Chromium Stents (CCS) Forecast by Region (2024-2029)
12.1.2 Global Cobalt Chromium Stents (CCS) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cobalt Chromium Stents (CCS) Forecast by Type
12.7 Global Cobalt Chromium Stents (CCS) Forecast by Application
13 Key Players Analysis
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.1.3 Boston Scientific Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Medtronic, Inc.
13.2.1 Medtronic, Inc. Company Information
13.2.2 Medtronic, Inc. Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.2.3 Medtronic, Inc. Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic, Inc. Main Business Overview
13.2.5 Medtronic, Inc. Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.3.3 Abbott Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Lepu Medical
13.4.1 Lepu Medical Company Information
13.4.2 Lepu Medical Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.4.3 Lepu Medical Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lepu Medical Main Business Overview
13.4.5 Lepu Medical Latest Developments
13.5 MicroPort Scientific Corporation
13.5.1 MicroPort Scientific Corporation Company Information
13.5.2 MicroPort Scientific Corporation Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.5.3 MicroPort Scientific Corporation Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MicroPort Scientific Corporation Main Business Overview
13.5.5 MicroPort Scientific Corporation Latest Developments
13.6 Cook Medical
13.6.1 Cook Medical Company Information
13.6.2 Cook Medical Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.6.3 Cook Medical Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cook Medical Main Business Overview
13.6.5 Cook Medical Latest Developments
13.7 Terumo
13.7.1 Terumo Company Information
13.7.2 Terumo Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.7.3 Terumo Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Terumo Main Business Overview
13.7.5 Terumo Latest Developments
13.8 Biosensors International
13.8.1 Biosensors International Company Information
13.8.2 Biosensors International Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.8.3 Biosensors International Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biosensors International Main Business Overview
13.8.5 Biosensors International Latest Developments
13.9 Balton
13.9.1 Balton Company Information
13.9.2 Balton Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.9.3 Balton Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Balton Main Business Overview
13.9.5 Balton Latest Developments
13.10 AlviMedica Medical Technologies
13.10.1 AlviMedica Medical Technologies Company Information
13.10.2 AlviMedica Medical Technologies Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.10.3 AlviMedica Medical Technologies Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 AlviMedica Medical Technologies Main Business Overview
13.10.5 AlviMedica Medical Technologies Latest Developments
13.11 Biotronik
13.11.1 Biotronik Company Information
13.11.2 Biotronik Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.11.3 Biotronik Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Biotronik Main Business Overview
13.11.5 Biotronik Latest Developments
13.12 Shandong JW Medical
13.12.1 Shandong JW Medical Company Information
13.12.2 Shandong JW Medical Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.12.3 Shandong JW Medical Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shandong JW Medical Main Business Overview
13.12.5 Shandong JW Medical Latest Developments
13.13 Sino Medical
13.13.1 Sino Medical Company Information
13.13.2 Sino Medical Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.13.3 Sino Medical Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sino Medical Main Business Overview
13.13.5 Sino Medical Latest Developments
13.14 Beijing AMSINO
13.14.1 Beijing AMSINO Company Information
13.14.2 Beijing AMSINO Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.14.3 Beijing AMSINO Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Beijing AMSINO Main Business Overview
13.14.5 Beijing AMSINO Latest Developments
13.15 Liaoning Biomedical Materials R&D Center Co.(LBC)
13.15.1 Liaoning Biomedical Materials R&D Center Co.(LBC) Company Information
13.15.2 Liaoning Biomedical Materials R&D Center Co.(LBC) Cobalt Chromium Stents (CCS) Product Portfolios and Specifications
13.15.3 Liaoning Biomedical Materials R&D Center Co.(LBC) Cobalt Chromium Stents (CCS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Liaoning Biomedical Materials R&D Center Co.(LBC) Main Business Overview
13.15.5 Liaoning Biomedical Materials R&D Center Co.(LBC) Latest Developments
14 Research Findings and Conclusion
※参考情報 コバルトクロムステント(CCS)は、心血管疾患における血管内治療に用いられる医療機器で、特に狭心症や心筋梗塞の治療において重要な役割を果たしています。これらのステントは、金属製の網状のチューブであり、血管が狭くなったり、閉塞したりした部位に挿入され、血流を再度確保するために用いられます。特にコバルトとクロムを主成分とする合金は、その特性により、医療機器として非常に広く使用されています。 コバルトクロムは、強度と耐腐食性が高く、体内での生体適合性も優れています。そのため、CCSは血管に長期間留置されても、体に対する悪影響を最小限に抑えることができ、事故や合併症のリスクを減らすことができるため、心臓の冠動脈に非常に適した材料です。さらに、この合金の特性として、軽量でありながら高い強度を持ち、細い血管にも挿入しやすいという利点があります。 CCSにはいくつかの種類があります。代表的なものとしては、薬剤溶出ステント(DES)があります。これは、ステントの表面に抗生物質や抗炎症薬がコーティングされており、組織の増殖を抑制するために設計されています。これにより、再狭窄のリスクが低減され、患者の長期的な予後が改善される可能性があります。また、バイオ吸収性ステントも注目されています。これは、体内で自然に分解され、年月が経つにつれて体に吸収されます。これにより、長期的な合併症のリスクを軽減することができるため、特に期待されています。 コバルトクロムステントの主な用途は、狭心症や心筋梗塞といった心血管疾患の治療に限られず、末梢動脈疾患や腎血管疾患に対しても使用されることがあります。これにより、さまざまな病状に対して効果的な治療法を提供することができます。CCSの導入により、経皮的冠動脈形成術(PTCA)が進化し、患者にとってはより低侵襲な治療法が選択できるようになりました。 関連技術としては、心血管疾患の診断や治療における画像診断技術の進展があります。これには、血管造影やCTスキャン、MRIなどが含まれ、病変の特定や評価が可能です。また、ロボティック技術の進化により、より精密な手術が実現し、医師の操作精度を向上させることができます。これにより、ステントの挿入がより安全かつ効果的に行えるようになっています。 さらに、新しい材料や表面処理技術の開発が進んでおり、これにより血栓形成のリスクをさらに低減することが期待されています。コバルトクロムステントの効果的な使用に向けては、今後も新しい研究と技術革新が必要です。治療結果の質を向上させるために、医師と患者の情報共有や治療方針の合意形成が重要です。患者個々の病状やライフスタイルに応じた個別化医療の推進が期待されます。 CCSは今後も心血管疾患の治療において重要な位置を占めると考えられており、医療業界における不断の革新が求められています。新しい技術や材料が確立されることによって、さらなる効果的な治療法が登場し、患者の生活の質が向上することが期待されます。また、コバルトクロムステントは、長期的な視点での健康管理や生活習慣の改善とも密接に関連しており、患者教育やリハビリテーションの重要性も高まっています。そのため、医療従事者は患者に対して、CCSに関する正確な知識と治療の意味を伝え、共に健康を選択していくプロセスを大切にすることが大切です。 最後に、コバルトクロムステントは心血管治療の一翼を担っており、今後もその技術や応用の幅は広がることでしょう。新たなアイデアや技術の発展が、より多くの患者に恩恵をもたらすことを期待します。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/